Suppr超能文献

首个高效且选择性的非肽类神经肽Y Y1受体拮抗剂:BIBP3226。

The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226.

作者信息

Rudolf K, Eberlein W, Engel W, Wieland H A, Willim K D, Entzeroth M, Wienen W, Beck-Sickinger A G, Doods H N

机构信息

Division of Pharma Research, Dr. Karl Thomae GmbH, Biberach, Germany.

出版信息

Eur J Pharmacol. 1994 Dec 27;271(2-3):R11-3. doi: 10.1016/0014-2999(94)90822-2.

Abstract

The design and subsequent in vitro and in vivo biological characterisation of the first potent and selective non-peptide neuropeptide Y Y1 receptor antagonist, BIBP3226 ((R)-N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-argininami de) is reported. BIBP3226 displaced 125I-labelled neuropeptide Y with high affinity (Ki = 7 nM) from the human neuropeptide Y Y1 receptor and proved to be highly selective. BIBP3226 displayed potent antagonistic properties both in in vitro and in vivo models and thus represents the first selective non-peptide neuropeptide Y Y1 receptor antagonist.

摘要

本文报道了首个强效、选择性非肽类神经肽Y Y1受体拮抗剂BIBP3226((R)-N2-(二苯基乙酰基)-N-[(4-羟基苯基)甲基]-精氨酰胺)的设计及其后续的体外和体内生物学特性研究。BIBP3226能以高亲和力(Ki = 7 nM)从人神经肽Y Y1受体上取代125I标记的神经肽Y,且具有高度选择性。BIBP3226在体外和体内模型中均表现出强效的拮抗特性,因此是首个选择性非肽类神经肽Y Y1受体拮抗剂。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验